In prior work, we demonstrated reduced aortic allograft inflammation and vasculopathy at later follow up times (4 weeks) in Ndst1−/− donor aortic grafts and after M-T7 treatment in WT aortic allografts19. Here, NDST1 is linked to vascular disorder.